- 05 November, 2024
Foreign Affairs, Geopolitics & National SecurityBharat Biotech
Brazil to suspend Covaxin vaccine deal
Brasilia [Brazil], June 30 (ANI): Amid a probe into accusations of irregularities against President Jair Bolsonaro, Brazil's health minister has announced that the country will suspend a USD 324 million…
Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources
By Shalini Bhardwaj New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its…
DCGI’s expert panel to review Phase III data of Covaxin today
By Shalini Bhardwaj And Sahil Pandey New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat…
Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI: Govt sources
By Shalini Bhardwaj New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller…
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
By Shalini Bhardwaj New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use…
Covid-19: No newborn calf serum in final Covaxin product, says Health ministry, Bharat Biotech
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech. The…
AIIMS Delhi to start Covaxin trials on children in few days, say sources
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous…
Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by July-end: Dr NK Arora
With ramping up of production capacities, nearly 25 crore 'Made in India' vaccines are expected to be available by August, a senior official has said and noted that it will…
